EVARREST is a Topical Patch in the Plasma Derivative category. It is labeled and distributed by Ethicon, Inc.. The primary component is Fibrinogen Human; Human Thrombin.
| Product ID | 63713-050_3bce3aef-3db1-4a3c-94fe-943f878e1dc7 |
| NDC | 63713-050 |
| Product Type | Plasma Derivative |
| Proprietary Name | EVARREST |
| Generic Name | Fibrinogen Human And Human Thrombin |
| Dosage Form | Patch |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2013-03-01 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125392 |
| Labeler Name | Ethicon, Inc. |
| Substance Name | FIBRINOGEN HUMAN; HUMAN THROMBIN |
| Active Ingredient Strength | 9 mg/cm2; [iU]/cm2 |
| Pharm Classes | Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |
| Marketing Start Date | 2013-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125392 |
| Product Type | PLASMA DERIVATIVE |
| Marketing Start Date | 2013-03-01 |
| Marketing Category | BLA |
| Application Number | BLA125392 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2013-03-01 |
| Marketing Category | BLA |
| Application Number | BLA125392 |
| Product Type | PLASMA DERIVATIVE |
| Marketing Start Date | 2013-03-01 |
| Marketing End Date | 2020-02-04 |
| Ingredient | Strength |
|---|---|
| FIBRINOGEN HUMAN | 8.6 mg/cm2 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EVARREST 85758636 4585142 Live/Registered |
JOHNSON & JOHNSON 2012-10-19 |
![]() EVARREST 77671639 4225953 Live/Registered |
Johnson & Johnson 2009-02-17 |